INT86883

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.01
First Reported 1999
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 2
Total Number 5
Disease Relevance 3.00
Pain Relevance 0

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

isomerase activity (Tbxas1) oxidoreductase activity (Tbxas1) endoplasmic reticulum (Tbxas1)
Anatomy Link Frequency
spinal 1
blood 1
coronary artery 1
Tbxas1 (Mus musculus)
Pain Link Frequency Relevance Heat
aspirin 2 50.00 Quite Low
headache 4 5.00 Very Low Very Low Very Low
cva 4 5.00 Very Low Very Low Very Low
Angina 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Scoliosis 84 99.04 Very High Very High Very High
Neuroleptic Malignant Syndrome 40 98.84 Very High Very High Very High
Pressure Volume 2 Under Development 153 98.48 Very High Very High Very High
Hemorrhage 13 98.24 Very High Very High Very High
Myocardial Infarction 5 96.04 Very High Very High Very High
Cv General 3 Under Development 1 94.48 High High
Postoperative Hemorrhage 8 82.96 Quite High
Arthropathy 4 58.40 Quite High
Renal Failure 32 5.00 Very Low Very Low Very Low
Thrombosis 16 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
METHODS: The efficacy of aprotinin and tranexamic acid (TXA) was examined in a prospective, randomized, double-blind trial involving 56 patients scheduled for coronary artery bypass grafting and who received aspirin 100 mg/day until the day of the operation.
Regulation (efficacy) of TXA in coronary artery
1) Confidence 0.01 Published 1999 Journal J Card Surg Section Body Doc Link 10709819 Disease Relevance 0.29 Pain Relevance 0
The goal of this proposal is to perform a randomized, prospective, double blind study comparing the relative efficacy of TXA, EACA, and controls in AIS, NMS, and AD patients.
Regulation (efficacy) of TXA associated with scoliosis and neuroleptic malignant syndrome
2) Confidence 0.01 Published 2010 Journal BMC Surg Section Body Doc Link PMC2858129 Disease Relevance 0.93 Pain Relevance 0
Overall, orthopedic studies have demonstrated the efficacy of TXA and EACA over placebo in relation to blood loss [8-16].
Regulation (efficacy) of TXA in blood associated with pressure volume 2 under development
3) Confidence 0.01 Published 2010 Journal BMC Surg Section Body Doc Link PMC2858129 Disease Relevance 0.77 Pain Relevance 0
Here we propose a prospective, randomized, double-blinded control study evaluating the effects of TXA, EACA, and placebo for treatment of adolescent idiopathic scoliosis (AIS), neuromuscular scoliosis (NMS), and adult deformity (AD) via corrective spinal surgery.
Regulation (effects) of TXA in spinal associated with scoliosis and neuroleptic malignant syndrome
4) Confidence 0.01 Published 2010 Journal BMC Surg Section Abstract Doc Link PMC2858129 Disease Relevance 0.77 Pain Relevance 0
In a similar fashion, these consecutive de-identified ID numbers (151 to 390) were randomly assigned to TXA, EACA or control.
Regulation (control) of TXA
5) Confidence 0.01 Published 2010 Journal BMC Surg Section Body Doc Link PMC2858129 Disease Relevance 0.24 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox